Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea after a Mounjaro injection is the most common side effect people notice, and it usually peaks in the day or two after the shot before easing off. It happens because tirzepatide slows gastric emptying — your stomach empties more slowly than it's used to, which the brain reads as queasiness. For most people it settles within one to two weeks of starting or stepping up a dose. These are prescription-only medicines assessed by a clinician before they're prescribed; if your symptoms feel unmanageable, that's exactly the conversation to have with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the morning after you've injected. You feel fine, then a few hours in the queasiness arrives, sometimes mild, sometimes enough to put you off your coffee. That's tirzepatide's gastric-slowing effect in full swing. The medicine activates two gut-hormone receptors (GIP and GLP-1) that signal fullness and reduce appetite; as a side effect of that same mechanism, food moves through your stomach more slowly than usual.
Your body isn't accustomed to this pace yet. The result is a stomach that feels heavy or unsettled even when you haven't eaten much. The NHS tirzepatide medicines page lists nausea as the most reported side effect, and clinical experience confirms it clusters in the first week at each new dose level.
The good news is that it's self-limiting for most people. Your gut adapts. By the second or third week on a given dose, many people find the feeling has mostly passed. That's why Mounjaro's dosing schedule begins at 2.5mg, the first pen's job is to let your system adjust before the therapeutic dose kicks in, rather than to produce significant weight change immediately.
If you want a closer look at why feeling sick after Mounjaro happens and what to expect, that page covers it in more detail alongside how the pattern tends to evolve. If you're curious about how this pattern differs across different stages of tirzepatide treatment, that page covers it in more detail.
There's no single fix, but there are several things that compound well together. Timing your injection for an evening when you don't have an early start the next morning gives you the option to rest through the worst of it. Eating smaller amounts more frequently (rather than two or three large meals) prevents the stomach from being overwhelmed when it's already sluggish.
Fatty, rich or heavily spiced food makes things worse; bland starchy options (plain crackers, toast, boiled rice) are less provocative to a slow-emptying stomach. Cold or room-temperature food tends to be easier than hot food, which can heighten nausea. Sipping water regularly through the day matters too, practical strategies for managing nausea on Mounjaro covers the hydration angle in depth.
One detail worth mentioning: some people keep their pen in the fridge door next to the milk and inject on a Sunday evening so any rough hours fall on a quieter Monday rather than a busy workday. That kind of routine adjustment is low-effort and can make a real difference to how manageable the week feels.
Ginger (in tea, biscuit or capsule form) has modest evidence behind it for general nausea and is safe alongside tirzepatide for most people, though any supplement questions are worth running past your prescriber. Anti-nausea medication can also be prescribed if the queasiness is significant; your prescribing team can advise.
Most post-injection nausea is uncomfortable but not dangerous. The picture changes, though, if the nausea is accompanied by severe, persistent stomach pain, particularly pain that radiates to the back, with or without vomiting. That pattern can indicate acute pancreatitis, which the MHRA highlighted in a January 2026 Drug Safety Update on GLP-1 medicines as a known but infrequent serious side effect. It requires urgent medical attention, not a wait-and-see approach.
Similarly, if vomiting is frequent enough that you're struggling to keep water down, dehydration becomes a real concern. Signs of dehydration (dizziness, very dark urine, feeling faint) are a prompt to seek help the same day. You can report suspected side effects via the MHRA's Yellow Card scheme, which also helps regulators monitor patterns across all patients using these medicines.
There's a broader overview of the full Mounjaro side effect profile if you want to understand where nausea sits relative to other reactions people report. For anything dose-specific (whether nausea changes at 5mg or higher) the side effects at the 5mg dose page goes into more granular detail.
Persistent or severe nausea isn't something to push through silently. If queasiness is still significant after two to three weeks on a dose, or is bad enough to affect your ability to eat and function, your prescriber can consider slowing the titration schedule, staying longer at a lower dose before moving up. That approach often resolves the problem without abandoning treatment.
Some people find that nausea tied specifically to eating on Mounjaro responds well to changing meal composition rather than dose changes; those two issues overlap but have different levers.
Mounjaro is a prescription-only medicine, and the clinical relationship that comes with a legitimate prescription is part of how it's meant to be used safely. At nume, our prescribing team reviews every consultation personally, if you're finding the side effects hard to manage, the aftercare line is there seven days a week.
For those still weighing up treatment options more broadly, our weight-loss treatment overview sets out what's available and how the options compare. And if you're ready to check whether tirzepatide is appropriate for you, the best next step is to start a free consultation so a prescriber can assess the full picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.